Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.23 USD | +0.48% | +15.37% | -34.07% |
May. 06 | Lendway Names Elizabeth McShane CFO | MT |
May. 01 | Transcript : Regis Corporation, Q3 2024 Earnings Call, May 01, 2024 |
Financials (USD)
Sales 2022 | 276M | Sales 2023 | 233M | Capitalization | 50.58M |
---|---|---|---|---|---|
Net income 2022 | -85M | Net income 2023 | -7M | EV / Sales 2022 | 2.62 x |
Net Debt 2022 | 675M | Net Debt 2023 | 541M | EV / Sales 2023 | 2.54 x |
P/E ratio 2022 |
-0.38
x | P/E ratio 2023 |
-6.95
x | Employees | 435 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.59% |
Latest transcript on Regis Corporation
1 day | +6.71% | ||
1 week | +19.46% | ||
Current month | +18.10% | ||
1 month | -10.53% | ||
3 months | -49.80% | ||
6 months | -34.72% | ||
Current year | -34.39% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Doctor
CEO | Chief Executive Officer | 37 | 21-01-31 |
Kersten Zupfer
DFI | Director of Finance/CFO | 49 | 06-12-31 |
Jim Lain
COO | Chief Operating Officer | 60 | 13-11-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Mansbach
BRD | Director/Board Member | 56 | 21-06-13 |
Margaret Rhoades
BRD | Director/Board Member | 79 | 15-10-19 |
Michael Merriman
BRD | Director/Board Member | 67 | 11-10-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 6.23 | +0.48% | 1 496 |
24-05-08 | 6.2 | +6.71% | 4,502 |
24-05-07 | 5.81 | +4.68% | 15,097 |
24-05-06 | 5.55 | +0.73% | 6,482 |
24-05-03 | 5.51 | +2.04% | 7,795 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-34.39% | 14.14M | |
+50.54% | 489M | |
-26.36% | 386M | |
+3.45% | 278M | |
-15.52% | 202M | |
-24.67% | 95.54M | |
-3.77% | 81.23M | |
-20.49% | 71.81M | |
-25.93% | 63.03M | |
-12.41% | 64.98M |
- Stock Market
- Equities
- RGS Stock